We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Name | Symbol | Market | Type |
|---|---|---|---|
| Reckitt Benckiser PLC (PK) | USOTC:RBGLY | OTCMarkets | Depository Receipt |
| Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.03 | 0.26% | 11.36 | 11.31 | 11.45 | 11.45 | 11.27 | 11.27 | 623,198 | 21:42:26 |
From May 2021 to May 2024
By Sabela Ojea
Reckitt Benckiser Group PLC said Friday it is proposing to sell its E45 skincare brand and related sub-brands to Karo Pharma AB for an implied enterprise value of 200 million pounds ($268.2 million).
The consumer-goods company--which houses Dettol, Harpic and Durex among its brands--said E45 generated a combined net revenue of GBP43 million for the year ended Dec. 31, 2020.
"The proposed sale, if completed, would be another step forward in Reckitt's plan to actively manage its portfolio for higher growth," the London-listed company said.
The transaction is expected to be completed in the first quarter of 2022, it said.
Write to Sabela Ojea at sabela.ojea@wsj.com; @sabelaojeaguix
(END) Dow Jones Newswires
December 24, 2021 02:31 ET (07:31 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
1 Year Reckitt Benckiser (PK) Chart |
1 Month Reckitt Benckiser (PK) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
